Chimeric proteins consisting of a targeting moiety and a cytotoxic moiety are now under intense research focus for targeted therapy of cancer. Here， we report cloning， expression， and purification of such a targeted chimeric protein made up of p28 peptide as both targeting and anticancer moiety fused to NRC peptide as a cytotoxic moiety. However， since the antimicrobial activity of the NRC peptide would intervene expression of the chimeric protein in Escherichia coli， we evaluated the effects of two fusion tags， that is， thioredoxin (Trx) and 6x-His tags， and various expression conditions， on the expression of p28-NRC chimeric protein.
Chimeric proteins consisting of a targeting moiety and a cytotoxic moiety are now under intense research focus for targeted therapy of cancer. Here， we report cloning， expression， and purification of such a targeted chimeric protein made up of p28 peptide as both targeting and anticancer moiety fused to NRC peptide as a cytotoxic moiety. However， since the antimicrobial activity of the NRC peptide would intervene expression of the chimeric protein in Escherichia coli， we evaluated the effects of two fusion tags， that is， thioredoxin (Trx) and 6x-His tags， and various expression conditions， on the expression of p28-NRC chimeric protein.
